Insider Selling: XOMA Corp CEO Unloads 10,000 Shares of Stock (XOMA)
XOMA Corp (NASDAQ:XOMA) CEO John Varian sold 10,000 shares of XOMA Corp stock in a transaction dated Tuesday, July 15th. The stock was sold at an average price of $4.03, for a total value of $40,300.00. Following the completion of the sale, the chief executive officer now directly owns 285,613 shares in the company, valued at approximately $1,151,020. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Shares of XOMA Corp (NASDAQ:XOMA) opened at 3.70 on Friday. XOMA Corp has a 1-year low of $3.42 and a 1-year high of $9.57. The stock has a 50-day moving average of $4.45 and a 200-day moving average of $5.65. The company’s market cap is $395.5 million. XOMA Corp also was the recipient of a large decline in short interest during the month of June. As of June 30th, there was short interest totalling 6,975,241 shares, a decline of 27.6% from the June 13th total of 9,634,353 shares. Based on an average daily volume of 2,117,646 shares, the short-interest ratio is currently 3.3 days. Approximately 6.6% of the company’s shares are short sold.
XOMA Corp (NASDAQ:XOMA) last posted its quarterly earnings results on Wednesday, May 7th. The company reported ($0.23) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.17) by $0.06. The company had revenue of $3.41 million for the quarter, compared to the consensus estimate of $7.40 million. During the same quarter last year, the company posted ($0.30) earnings per share. XOMA Corp’s revenue was down 63.9% compared to the same quarter last year. Analysts expect that XOMA Corp will post $-0.65 EPS for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Wedbush raised their price target on shares of XOMA Corp to $14.00 in a research note on Monday, May 12th. They now have an “outperform” rating on the stock. Analysts at MLV & Co
upgraded shares of XOMA Corp from a “hold” rating to a “buy” rating in a research note on Tuesday, April 29th. They now have a $7.00 price target on the stock. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and six have given a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $9.11.
XOMA Corporation (NASDAQ:XOMA) is engaged in the discovery and development of antibody-based therapeutics.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.